Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index

Arthritis Care and Research

Volumn 55, Issue 4, 2006, Pages 575-582

  Maksymowych, Walter P ^a   Mallon, Cathy ^a   Richardson, Rhonda ^a   Conner Spady, Barbara ^a   Jauregui, Edwin ^b   Chung, Cecilia ^a   Zappala, Lisa ^c   Pile, Kevin ^c   Russell, Anthony S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CAYRE Arthritis and Rehabilitation Clinic   (Colombia)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Ankylosing spondylitis; Index; Spinal and hip mobility; Validation

Indexed keywords

PAMIDRONIC ACID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; AUSTRALIA; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CANADA; COLOMBIA; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; DISEASE ACTIVITY; EDMONTON ANKYLOSING SPONDYLITIS METROLOGY INDEX; FEMALE; HIP; HUMAN; JOINT MOBILITY; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; RELIABILITY; SCORING SYSTEM; SPINE; VALIDATION PROCESS;

ADULT; DIPHOSPHONATES; FEMALE; HIP JOINT; HUMANS; MALE; OBSERVER VARIATION; RANGE OF MOTION, ARTICULAR; RECEPTORS, TUMOR NECROSIS FACTOR; REPRODUCIBILITY OF RESULTS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 33747888630     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22103     Document Type: Article

References (36)

1. Van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis: progress report of the ASAS Working Group: assessments in ankylosing spondylitis. J Rheumatol 1999;26:951-4.
2. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M. Sensitivity to change of mobility tests: effect of short term intensive physiotherapy and exercise on spinal, hip, and shoulder measurements in spondyloarthropathy. J Rheumatol 2000;27: 1251-6.
3. Auleley GR, Benbouazza K, Spoorenberg A, Collantes E, Hajjaj-Hassouni N, van der Heijde D, et al. Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis Rheum 2002;47:582-7.
4. Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RI, Hitchon C, et al. The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004; 31:1126-31.
5. Viitanen JV, Heikkila S, Kokko ML, Kautiainen H. Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol 2000;19:131-7.
6. Viitanen JV, Kautiainen H, Suni J, Kokko ML, Lehtinen K. The relative value of spinal and thoracic mobility measurements in ankylosing spondylitis. Scand J Rheumatol 1995;24:94-7.
7. Roberts WN, Larson MG, Liang MH, Harrison RA, Barefoot J, Clarke AK. Sensitivity of anthropometric techniques for clinical trials in ankylosing spondylitis. Br J Rheumatol 1989;28: 40-5.
8. Nissila M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U. Sulfasalazine in the treatment of ankylosing spondylitis: a twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 1988;31:111-6.
9. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med 2002;346:1349-56.
10. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Denning spinal mobility in ankylosing spondylitis (AS): the Bath AS metrology index. J Rheumatol 1994; 21:1694-8.
11. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359: 1187-93.
12. Van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, et al, and the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582-91.
13. Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. J Rhematol 2004;31:2422-8.
14. Viitanen JV, Kokko ML, Heikkila S, Kautiainen H. Neck mobility assessment in ankylosing spondylitis: a clinical study of nine measurements including new tape methods for cervical rotation and lateral flexion. Br J Rheumatol 1998;37:377-81.
15. Viitanen JV, Kautiainen H, Kokko ML, Ala-Peijari S. Age and spinal mobility in ankylosing spondylitis. Scand J Rheumatol 1995;24:314-5.
16. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36: 766-71.
17. O'Driscoll SL, Jayson MI, Baddeley H. Neck movements in ankylosing spondylitis and their responses to physiotherapy. Ann Rheum Dis 1978;37:64-6.
18. Tomlinson MJ, Barefoot J, Dixon AS. Intensive in-patient physiotherapy courses improve movement and posture in ankylosing spondylitis. Physiotherapy 1986;5:238-40.
19. Viitanen JV, Suni J, Kautiainen H, Liimatainen M, Takala H. Effect of physiotherapy on spinal mobility in ankylosing spondylitis. Scand J Rheumatol 1992;21:38-41.
20. Bellamy N. Clinimetric concepts in outcome assessment: the OMERACT filter. J Rheumatol 1999;26:948-50.
21. Pile KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO. Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 1991;30:29-34.
22. Haywood KL, Garratt AM, Jordan K, Dziedzic K, Dawes PT. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2004;43:750-7.
23. Holden W, Taylor S, Stevens H, Wordsworth P, Bowness P. Neck pain is a major clinical problem in ankylosing spondylitis, and impacts on driving and safety. Scand J Rheumatol 2005;34:159-60.
24. Domjan L, Nemes T, Balint GP, Toth Z, Gomor B. A simple method for measuring lateral flexion of the dorsolumbar spine. J Rheumatol 1990;17:663-5.
25. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361-8.
26. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
27. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Malorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21: 2281-5.
28. Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. A radiographic scoring system and identification of variables measuring structural damage in ankylosing spondylitis [thesis]. Nijmegen, The Netherlands: University of Nijmegen; 1994.
29. MacKay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998;41:2263-70.
30. Glass GV, Hopkins KD. Statistical methods in education and psychology. 3rd ed. Needham Heights (MA): Allyn and Bacon; 1996.
31. Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) [letter]. J Rheumatol 1995; 22:1609.
32. Haywood KL. Health outcomes in ankylosing spondylitis: an evaluation of patient-based and anthropometric measures [DPhil thesis]. York, UK: University of York; 2000.
33. Roberts WN, Liang MH, Pallozzi LM, Daltroy LH. Effects of warming up on reliability of anthropometric techniques in ankylosing spondylitis. Arthritis Rheum 1988;31:549-52.
34. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. J Rheumatol 1999;26:975-9.
35. Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al, and the Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6.
36. Wanders AJ, Gorman JD, Davis JC, Landewe RB, van der Heijde DM. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis. Arthritis Rheum 2004;51:1-8.